Jiangzhong Pharmaceutical

Founded in 1996, Jiangzhong Pharmaceutical is a Chinese company based in Nanchang that focuses on developing and manufacturing pharmaceutical products to improve health outcomes. Jiangzhong Pharmaceutical specializes in the development and production of a wide range of pharmaceutical products. The company was founded in 1996 in Nanchang, China. The firm has engaged in strategic investments, with its most recent deal occurring on December 19, 2021, when it raised an undisclosed amount from Aladdin Family Office.

There is no public information regarding any subsidiaries or parent companies. Jiangzhong Pharmaceutical offers a diverse array of pharmaceutical products aimed at addressing various health needs. Their product line includes traditional Chinese medicine formulations, modern pharmaceuticals, and over-the-counter remedies. These products cater to a broad spectrum of health conditions and are developed to meet the needs of healthcare providers and patients alike.

The company serves a wide range of clients, including healthcare institutions and retail pharmacies, ensuring accessibility to their products across the healthcare sector. In the most recent fiscal year, Jiangzhong Pharmaceutical reported a revenue of USD 618. 02 mn and an EBITDA of USD 162. 13 mn.

Their revenue model is built on direct sales of pharmaceutical products and ongoing support services, which provide a steady income stream. Jiangzhong Pharmaceutical aims to enhance its product offerings by launching new pharmaceutical formulations in the upcoming year. They plan to expand into additional markets, targeting regions in Southeast Asia and Europe by the end of 2024. The recent funding round will support these initiatives, allowing the company to invest in research and development and market entry strategies.